Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have been given a consensus rating of “Hold” by the nine ratings firms that are currently covering the stock. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $58.43.
Several research analysts have recently weighed in on NUS shares. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, May 6th. Sidoti downgraded Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price for the company. in a research note on Wednesday, April 26th. Jefferies Group LLC set a $52.00 target price on Nu Skin Enterprises and gave the stock a “hold” rating in a research note on Friday, February 17th. Deutsche Bank AG reiterated a “buy” rating and set a $63.00 price target on shares of Nu Skin Enterprises in a research report on Sunday, February 19th. Finally, Pivotal Research reiterated a “buy” rating and set a $65.00 price target on shares of Nu Skin Enterprises in a research report on Thursday, May 4th.
Shares of Nu Skin Enterprises (NYSE:NUS) traded up 1.28% during trading on Tuesday, reaching $56.26. 119,428 shares of the company traded hands. The company’s 50-day moving average price is $55.59 and its 200-day moving average price is $52.72. The company has a market capitalization of $2.97 billion, a P/E ratio of 18.67 and a beta of 1.66. Nu Skin Enterprises has a 52 week low of $38.19 and a 52 week high of $66.04.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, May 3rd. The company reported $0.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.01. The company had revenue of $499.10 million during the quarter, compared to the consensus estimate of $493.65 million. Nu Skin Enterprises had a return on equity of 20.06% and a net margin of 6.26%. Nu Skin Enterprises’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.42 earnings per share. Equities research analysts forecast that Nu Skin Enterprises will post $3.12 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 14th. Investors of record on Friday, May 26th will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.59%. The ex-dividend date is Wednesday, May 24th. Nu Skin Enterprises’s payout ratio is 57.96%.
WARNING: “Nu Skin Enterprises, Inc. (NUS) Receives $58.43 Consensus PT from Analysts” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2017/05/19/nu-skin-enterprises-inc-nus-given-average-recommendation-of-hold-by-analysts-updated.html.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of the stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $58.32, for a total value of $466,560.00. Following the sale, the general counsel now owns 53,730 shares of the company’s stock, valued at approximately $3,133,533.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In the last three months, insiders have sold 32,000 shares of company stock worth $1,708,960. 4.60% of the stock is owned by corporate insiders.
A number of large investors have recently bought and sold shares of NUS. Independent Portfolio Consultants Inc. raised its stake in Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares in the last quarter. New York State Teachers Retirement System increased its position in Nu Skin Enterprises by 2.1% in the fourth quarter. New York State Teachers Retirement System now owns 4,900 shares of the company’s stock worth $234,000 after buying an additional 100 shares during the last quarter. Suntrust Banks Inc. increased its position in Nu Skin Enterprises by 1.3% in the first quarter. Suntrust Banks Inc. now owns 8,117 shares of the company’s stock worth $450,000 after buying an additional 102 shares during the last quarter. BOKF NA increased its position in Nu Skin Enterprises by 3.4% in the third quarter. BOKF NA now owns 8,689 shares of the company’s stock worth $563,000 after buying an additional 286 shares during the last quarter. Finally, Vident Investment Advisory LLC increased its position in Nu Skin Enterprises by 0.8% in the fourth quarter. Vident Investment Advisory LLC now owns 45,168 shares of the company’s stock worth $2,158,000 after buying an additional 362 shares during the last quarter. 78.88% of the stock is currently owned by institutional investors.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.